Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BEAM
Stock Latest News
The Fly
Beam Therapeutics announces FDA grants RMAT designation to BEAM-302
15d ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising Gene Editing Advancements and Strategic Execution Reinforce Buy Rating
19d ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising Pipeline and Financial Stability Justify Buy Rating
19d ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising Advancements in Base Editing and Strong Financial Position Support Buy Rating
20d ago
BEAM
Premium
The Fly
Beam Therapeutics price target lowered to $55 from $78 at Guggenheim
20d ago
BEAM
VRTX
Premium
The Fly
Beam Therapeutics price target lowered to $70 from $75 at Wells Fargo
20d ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
20d ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising Growth Prospects and Strategic Advancements Support Buy Rating
20d ago
BEAM
Premium
The Fly
Beam Therapeutics price target lowered to $25 from $31 at Barclays
20d ago
BEAM
Premium
Company Announcements
Beam Therapeutics Reports Strong Q1 2025 Progress
21d ago
BEAM
Premium
The Fly
Beam Therapeutics reports Q1 EPS ($1.24), consensus ($1.17)
21d ago
BEAM
Premium
The Fly
Beam Therapeutics sees cash runway into 2028
21d ago
BEAM
Premium
The Fly
JPMorgan biotech/Euro pharma analysts hold analyst/industry conference call
1M ago
WVE
BEAM
Premium
The Fly
Cathie Wood’s ARK Investment buys 135K shares of Beam Therapeutics today
2M ago
BEAM
Premium
Ratings
Beam Therapeutics’ BEAM-302: Promising Clinical Data and Market Potential Drive Buy Rating
2M ago
BEAM
Premium
The Fly
Beam Therapeutics presents additional data for BEAM-302 in AATD
2M ago
BEAM
Premium
The Fly
Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics today
2M ago
BEAM
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
2M ago
DYN
MGX
Premium
The Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
2M ago
MGX
BEAM
Premium
The Fly
Beam Therapeutics upgraded to Buy at BofA after BEAM-302 data
2M ago
BEAM
Premium
The Fly
Beam Therapeutics upgraded to Buy from Neutral at BofA
2M ago
BEAM
Premium
The Fly
Beam announces FDA clearance of BEAM-302 investigational new drug application
2M ago
BEAM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
